tiprankstipranks
Laboratorios Farmaceuticos Rovi (GB:0ILL)
:0ILL
UK Market

Laboratorios Farmaceuticos Rovi (0ILL) Income Statement

Compare
0 Followers

Laboratorios Farmaceuticos Rovi Income Statement

Last quarter (Q4 2024), Laboratorios Farmaceuticos Rovi's total revenue was €434.41M, an increase of 85.14% from the same quarter last year. In Q4, Laboratorios Farmaceuticos Rovi's net income was €92.54M. See Laboratorios Farmaceuticos Rovi’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 763.75M€ 829.51M€ 817.70M€ 648.68M€ 419.96M
Gross Profit
€ 478.35M€ 483.34M€ 519.61M€ 384.82M€ 241.31M
Operating Expenses
€ 298.80M€ 263.09M€ 263.76M€ 203.34M€ 163.88M
Depreciation and Amortization
€ 28.02M€ 24.33M€ 22.87M€ 21.36M€ 19.59M
EBITDA
€ 207.69M€ 245.81M€ 281.49M€ 204.72M€ 93.28M
Operating Income
€ 179.54M€ 220.25M€ 255.85M€ 181.57M€ 74.68M
Other Income/Expenses
€ -1.85M€ 154.00K€ 1.92M€ 1.24M€ -2.07M
Pretax Income
€ 177.69M€ 220.41M€ 257.97M€ 182.63M€ 72.58M
Net Income
€ 136.88M€ 170.34M€ 199.67M€ 153.08M€ 61.06M
Per Share Metrics
Basic EPS
€ 2.67€ 3.29€ 3.73€ 2.76€ 1.10
Diluted EPS
€ 2.67€ 3.29€ 3.73€ 2.76€ 1.10
Weighted Average Shares Outstanding
51.27M 51.82M 53.47M 55.40M 55.39M
Weighted Average Shares Outstanding (Diluted)
51.27M 51.82M 53.47M 55.40M 55.39M
Currency in EUR

Laboratorios Farmaceuticos Rovi Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis